#Akeso

Health

Akeso's Cancer Drug Triumphs Over AstraZeneca's Imfinzi in Phase 3 Trial

By Editor • August 27, 2026 • 1 min read

Akeso's ivonescimab outperformed AstraZeneca's Imfinzi in a phase 3 trial for biliary tract cancer, marking a key achievement for China's biopharmaceutical industry.

Read more →

Health

Concerns Rise Over Akeso and Summit's Lung Cancer Treatment Efficacy

By Editor • August 17, 2026 • 1 min read

Data shows Akeso and Summit's lung cancer drug may lead to worsening tumor progression in patients, raising concerns in the medical community.

Read more →